SecBot SecBot
SECBOTREPLAY Home › Report › CNTA

CNTA · Centessa Pharmaceuticals C-suite executives sold over $7.2M in stock…

Centessa Pharmaceuticals plc · CLUSTER filed Mar 13, 2026 at 18:22 ET

At the news

BEARISHIMPACT 7/10

CLUSTER filed Mar 13, 2026 at 18:22 ET

Centessa Pharmaceuticals C-suite executives sold over $7.2M in stock within a week, primarily from Chief People Officer Karen Anderson's open-market sales of 215,922 shares. These sales followed derivative exercises and represent a material insider divestment.

  • Chief People Officer Karen Anderson sold 215,922 shares for $5.65M in open-market transactions at ~$26.15 per share
  • Anderson also exercised derivatives for 407,244 shares (some at $4.01, others at $0), with total economic value of $816,524.22
  • Chief Business Officer Gregory Weinhoff sold 61,253 shares for $1.6M
  • Total open-market sales by insiders: $7.25M over 7 days

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access